Cellular Physiology and Biochemistry · 2014 · 61 citations · 17 references
MedicineCancer BiologyOncologyGene ExpressionMolecular OncologyNeoplasiaCancer BiomarkersCancer Cell SignalingLung CancerMicrorna BiologyMicrorna-mediated RegulationTumor Suppressor GenesCox RegressionLung AdenocarcinomaLymph Node Metastasis PrognosisMicrorna Function In CancerMicrorna In CancerPrognostic BiomarkersReal-time Polymerase Chain Reaction (Pcr)Tumor Differentiation Assessment
BACKGROUND/AIMS: Dysregulation of microRNAs is correlated with tumor development. The aim of this study is to investigate the clinicopathologic and prognostic significance of microRNA (miR)-409-3p and its tumor suppressor roles in lung adenocarcinoma (LAD). METHODS: Quantitative real-time PCR (qRT-PCR) was performed to detect miR-409-3p expression in LAD tissues and corresponding noncancerous tissues. Additionally, the correlations of miR-409-3p expression with clinicopathologic factors and prognosis of patients were statistically analyzed. Next, we investigated whether miR-409-3p could function as a tumor suppressor in LAD cells via regulation of Akt signaling by targeting receptor tyrosine kinase (c-Met). RESULTS: MiR-409-3p was significantly downregulated in LAD tissues compared with corresponding noncancerous tissues. Low miR-409-3p expression was observed to be significantly correlated with poorer tumor differentiation, advanced pTNM stage and higher incidence of lymph node metastasis. Multivariate Cox regression analyses showed that miR-409-3p expression was an independent prognostic factor for LAD patients. Functional analyses indicated that miR-409-3p could inhibit growth, induce apoptosis, reduce migration and invasion in LAD cells via inactivation of Akt signaling by targeting c-Met. CONCLUSIONS: MiR-409-3p was an independent prognostic factor and functioned as a tumor suppressor in LAD via regulation of Akt signaling by targeting c-Met.
17
Kazuhiro Kitamura, Masahiro Seike, Tetsuya Okano et al. · Molecular Cancer Therapeutics · 2013 · 186 citations · Full text
Medicine, Cancer Biology, Oncology +17
c-MET Expression in Myofibroblasts
Masahide Tokunou, Toshiro Niki, Keisuke Eguchi et al. · American Journal Of Pathology · 2001 · 110 citations · Full text
MicroRNA Expression Profiles of Whole Blood in Lung Adenocarcinoma
Santosh K. Patnaik, Sai Yendamuri, Eric Kannisto et al. · PLoS ONE · 2012 · 109 citations · Full text
Medicine, Cancer Biology, Oncology +15
A MicroRNA Cluster at 14q32 Drives Aggressive Lung Adenocarcinoma
Ernest Nadal, Jinjie Zhong, Jules Lin et al. · Clinical Cancer Research · 2014 · 100 citations